Search research articles
Contact Us
Filters
Showing results (61-70 of 68) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 68 results.
European Annals of Otorhinolaryngology, Head and Neck Diseases
|
July 4, 2015
Guidelines (short version) of the French Otorhinolaryngology - Head and Neck Surgery Society (SFORL) on patient pathway organization in ENT: The therapeutic decision-making process
S Deneuve, E Babin, J Lacau-St-Guily, et al.
Revue Des Maladies Respiratoires
|
May 24, 2007
[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer]
V Westeel, M P Lebitasy, M Mercier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2016
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial
P M Clement, T Gauler, J P Machiels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 16, 2022
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial
Y Tao, J Biau, X S Sun, et al.
ESMO Open
|
May 1, 2025
A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
R Galot, C Le Tourneau, L Licitra, et al.
World Journal of Surgery
|
August 9, 2017
Histologically Proven Bronchial Neuroendocrine Tumors in MEN1: A GTE 51-Case Cohort Study
P Lecomte, C Binquet, M Le Bras, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer
E E W Cohen, L F Licitra, B Burtness, et al.
Bulletin Du Cancer
|
October 16, 2013
[Advances in head and neck cancers on behalf of the French Intergroup ORL and GORTEC]
J Thariat, F Jegoux, Y Pointreau, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 68) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 68 results.
European Annals of Otorhinolaryngology, Head and Neck Diseases
|
July 4, 2015
Guidelines (short version) of the French Otorhinolaryngology - Head and Neck Surgery Society (SFORL) on patient pathway organization in ENT: The therapeutic decision-making process
S Deneuve, E Babin, J Lacau-St-Guily, et al.
Revue Des Maladies Respiratoires
|
May 24, 2007
[IFCT-0302 trial: randomised study comparing two follow-up schedules in completely resected non-small cell lung cancer]
V Westeel, M P Lebitasy, M Mercier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 17, 2016
Afatinib versus methotrexate in older patients with second-line recurrent and/or metastatic head and neck squamous cell carcinoma: subgroup analysis of the LUX-Head & Neck 1 trial
P M Clement, T Gauler, J P Machiels, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 16, 2022
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial
Y Tao, J Biau, X S Sun, et al.
ESMO Open
|
May 1, 2025
A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
R Galot, C Le Tourneau, L Licitra, et al.
World Journal of Surgery
|
August 9, 2017
Histologically Proven Bronchial Neuroendocrine Tumors in MEN1: A GTE 51-Case Cohort Study
P Lecomte, C Binquet, M Le Bras, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Biomarkers predict enhanced clinical outcomes with afatinib versus methotrexate in patients with second-line recurrent and/or metastatic head and neck cancer
E E W Cohen, L F Licitra, B Burtness, et al.
Bulletin Du Cancer
|
October 16, 2013
[Advances in head and neck cancers on behalf of the French Intergroup ORL and GORTEC]
J Thariat, F Jegoux, Y Pointreau, et al.
Page
of 7